KalVista Pharmaceuticals Statistics Share Statistics KalVista Pharmaceuticals has 50.52M
shares outstanding. The number of shares has increased by 15.04%
in one year.
Shares Outstanding 50.52M Shares Change (YoY) 15.04% Shares Change (QoQ) 0% Owned by Institutions (%) 99.99% Shares Floating 37.87M Failed to Deliver (FTD) Shares 240 FTD / Avg. Volume 0.02%
Short Selling Information The latest short interest is 10.56M, so 20.98% of the outstanding
shares have been sold short.
Short Interest 10.56M Short % of Shares Out 20.98% Short % of Float 23.62% Short Ratio (days to cover) 18.45
Valuation Ratios The PE ratio is -3.73 and the forward
PE ratio is -3.92.
KalVista Pharmaceuticals's PEG ratio is
-0.51.
PE Ratio -3.73 Forward PE -3.92 PS Ratio 0 Forward PS 18.6 PB Ratio 7.17 P/FCF Ratio -4.47 PEG Ratio -0.51
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for KalVista Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.35,
with a Debt / Equity ratio of 0.07.
Current Ratio 5.35 Quick Ratio 5.35 Debt / Equity 0.07 Debt / EBITDA -0.04 Debt / FCF -0.04 Interest Coverage -32.5
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.22M Employee Count 150 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 3.39M Effective Tax Rate -1.88%
Stock Price Statistics The stock price has increased by 21% in the
last 52 weeks. The beta is -0.1, so KalVista Pharmaceuticals's
price volatility has been lower than the market average.
Beta -0.1 52-Week Price Change 21% 50-Day Moving Average 13.8 200-Day Moving Average 11.84 Relative Strength Index (RSI) 33.87 Average Volume (20 Days) 1,293,800
Income Statement
Revenue n/a Gross Profit -941K Operating Income -188M Net Income -183.44M EBITDA -173.33M EBIT -174.27M Earnings Per Share (EPS) -3.69
Full Income Statement Balance Sheet The company has 98.64M in cash and 6.31M in
debt, giving a net cash position of 92.34M.
Cash & Cash Equivalents 98.64M Total Debt 6.31M Net Cash 92.34M Retained Earnings -653.17M Total Assets 215.5M Working Capital 167.52M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -152.91M
and capital expenditures -434K, giving a free cash flow of -152.91M.
Operating Cash Flow -152.91M Capital Expenditures -434K Free Cash Flow -152.91M FCF Per Share -3.08
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields KALV does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for KALV is $27.5,
which is 127.3% higher than the current price. The consensus rating is "Buy".
Price Target $27.5 Price Target Difference 127.3% Analyst Consensus Buy Analyst Count 8
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 22, 2016. It was a
backward
split with a ratio of 1:14.
Last Split Date Nov 22, 2016 Split Type backward Split Ratio 1:14
Scores Altman Z-Score -3.33 Piotroski F-Score 3
